Prevalence and Extent of Glycemic Excursions in Well-controlled Patients with Type 2 Diabetes Mellitus Using Continuous Glucose-monitoring System
Overview
Authors
Affiliations
Background: Continuous glucose-monitoring system (CGMS) is a tool for assessment of glycemic excursions. Glucose variability is a risk factor independent of glycosylated hemoglobin (HbA1c) for diabetic complications; hence CGMS may be a better method for management of diabetes.
Aim: To evaluate the extent of glycemic excursions in well-controlled type 2 diabetic patients.
Setting And Design: The study was carried out in 21 diabetic patients on oral agents.
Materials And Methods: Patients underwent continuous glucose-monitoring by CGMS for 3 days. Number and duration of glycemic excursions, correlation coefficient (%) between CGMS and self-monitoring blood glucose (SMBG), mean absolute difference (%MAD) and complications of CGMS were analyzed.
Statistical Analyses: The statistical analyses were performed with the use of mean +/- SD, t-test and Mann-Whitney test.
Results: The mean age of patients was 51.9 +/- 9.7 years. The mean HbA1c was 6.7 +/- 0.38%. The mean number of glycemic readings was 753.6 +/- 203.5 times. The correlation coefficient was 0.83 and the MAD was 11.7 +/- 8.0%, which were considerable. Three (14.2%) patients experienced, altogether, 9 hypoglycemic events with an average duration of 162 minutes. Twenty (94.7%) patients had hyperglycemic events. The mean duration of hyperglycemia was 19.4 +/- 12.8 hours. All events were asymptomatic. Disconnection of device was the most common complication (3 patients).
Conclusion: This study demonstrated that well-controlled type 2 diabetic patients have a considerable number of hypoglycemia and hyperglycemia events that may be missed by SMBG.
Haraj N, Harouna Malam Brah N, Elaziz S, Chadli A Cureus. 2024; 16(10):e72710.
PMID: 39618608 PMC: 11606437. DOI: 10.7759/cureus.72710.
Li S, Huang Z, Lou D, Jiang Y, Zhao S BMC Surg. 2022; 22(1):314.
PMID: 35962366 PMC: 9373526. DOI: 10.1186/s12893-022-01762-1.
Paing A, McMillan K, Kirk A, Collier A, Hewitt A, Chastin S Prev Med Rep. 2018; 12:94-100.
PMID: 30214853 PMC: 6134430. DOI: 10.1016/j.pmedr.2018.09.002.
Jacobs B, Phan K, Bertheau L, Dogbey G, Schwartz F, Shubrook J J Diabetes Sci Technol. 2010; 4(3):636-44.
PMID: 20513330 PMC: 2901041. DOI: 10.1177/193229681000400318.